The effect of loratadine in exercise-induced asthma.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11806881.
- Also identified by PMC identifier 1719033.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the effect of loratadine in exercise induced asthma. Randomised, double blind, placebo controlled study of 10 mg oral loratadine, once daily for three days in 11 children. At the end of the treatment period FEV(1) was measured, and patients were exercised on a treadmill. FEV(1) measurements were repeated at intervals after exercise. Loratadine significantly reduced the decrease in FEV(1) after exercise at two, five, 10, 15, and 30 minutes, compared with placebo (p < 0.05). However, the mean decrease in FEV(1) at five minutes was more than 15% of baseline in the loratadine group. Loratadine reduces, but does not prevent, exercise induced asthma in children.
Medical subject headings
- Asthma, Exercise-Induced
- Histamine H1 Antagonists
- Loratadine